Showing results (121-130 of 276) with videos related to
Sort By:
Pageof 28
Biochemical and Biophysical Research Communications|May 26, 2004
A recombinant adenoviral vector encoding functional vasoactive intestinal peptideB M Lodde, C Delporte, C M Goldsmith, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Protective effect of an adenosine kinase inhibitor in septic shockG S Firestein, D Boyle, D A Bullough, et al.Nederlands Tijdschrift Voor Geneeskunde|September 6, 2007
[Arthritis psoriatica]M A de Rie, A W R van Kuijk, A Y Goedkoop, et al.Arthritis and Rheumatism|April 1, 2011
Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trialM C Genovese, N Kinnman, G de La Bourdonnaye, et al.The Journal of General Virology|May 9, 2007
Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in ratsJ Adriaansen, F J Fallaux, C J de Cortie, et al.Arthritis and Rheumatism|October 19, 2000
Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokinesI A Schrijver, M J Melief, P P Tak, et al.Scandinavian Journal of Rheumatology|January 6, 2006
The role of chemokines in rheumatoid arthritis and osteoarthritisC E Vergunst, M G H van de Sande, M C Lebre, et al.The Netherlands Journal of Medicine|November 8, 2011
Dermatomyositis and polymyositis: new treatment targets on the horizonA E Hak, B de Paepe, J L de Bleecker, et al.Annals of the Rheumatic Diseases|July 16, 2003
Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritisJ J Haringman, M C Kraan, T J M Smeets, et al.Oral Diseases|June 23, 2015
Cholinergic anti-inflammatory pathway in the non-obese diabetic mouse modelF A Koopman, J L Vosters, N Roescher, et al.Pageof 28